Loading...
XJPX
3649
Market cap148mUSD
Dec 05, Last price  
906.00JPY
1D
-0.88%
1Q
8.37%
Jan 2017
-4.43%
IPO
987.24%
Name

Findex Inc

Chart & Performance

D1W1MN
XJPX:3649 chart
P/E
19.80
P/S
3.94
EPS
45.76
Div Yield, %
1.66%
Shrs. gr., 5y
0.05%
Rev. gr., 5y
6.41%
Revenues
5.84b
+12.51%
772,034,0001,144,771,0001,543,160,0001,987,789,0002,382,635,0002,863,916,0002,951,922,0003,288,025,0003,311,714,0003,603,344,0004,281,539,0004,004,859,0004,968,885,0004,541,242,0005,191,735,0005,841,379,000
Net income
1.16b
+9.75%
84,893,000193,087,000221,961,000431,877,000517,836,000630,071,000441,399,000499,915,000366,628,000398,015,000499,249,000430,457,000636,027,000722,779,0001,059,140,0001,162,365,000
CFO
1.90b
+125.28%
116,549,000269,618,000171,846,000550,568,000556,521,0001,281,728,000126,962,0001,137,233,000580,488,000597,524,0001,670,010,000542,550,000750,353,000693,848,000842,844,0001,898,767,000
Dividend
Dec 29, 20259 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.
URL
https://findex.co.jp/
IPO date
Mar 23, 2011
Employees
282
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT